Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 59651-562

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 59651-562). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 2: Maintenance Of Healing Rates Of Ee In Adults By Month (study 177) (Esomeprazole Fig1)

A line graph depicting the percent maintained over a 6-month period for Esomeprazole Magnesium 40 mg, 20 mg, 10 mg, and placebo groups. The x-axis represents months with scheduled visits marked, and the y-axis shows percent maintained. Higher doses of Esomeprazole Magnesium correspond to higher percent maintained compared to placebo, with the 40 mg dose showing the highest maintenance.*

FDA Label Image

Figure 3: Maintenance Of Ee Healing Rates In Adults By Month (study 178) (Esomeprazole Fig2)

Line graph showing the percentage maintained over a 6-month period for Esomeprazole Magnesium at doses of 40 mg, 20 mg, 10 mg, and placebo. The x-axis represents months with scheduled visits, and the y-axis indicates the percent maintained, with higher doses showing greater maintenance over time compared to placebo.*

FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Esomeprazole Fig3)

Line graph showing the percent of patients symptom-free over 28 days for Esomeprazole Magnesium Delayed-Release Capsules 40 mg and 20 mg doses compared to placebo. The graph plots diary days on the x-axis and symptom-free percentage on the y-axis, with the 40 mg and 20 mg groups showing higher symptom-free percentages than placebo throughout the period.*

FDA Label Image

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Esomeprazole Fig4)

A line graph showing the percent of patients symptom-free over 28 diary days. It compares three groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and placebo. The 20 mg and 40 mg capsule groups show higher symptom-free percentages than placebo, with values increasing over time.*

FDA Label Image

Package Label-principal Display Panel (20 mg (30 Capsules Bottle))

Label for Esomeprazole Magnesium Delayed-Release Capsules USP 20 mg, packaged as 30 capsules. Distributed by Aurobindo Pharma USA, Inc., the label includes storage instructions and dosage form details. The label displays the NDC 59651-561-30, manufacturer Aurobindo Pharma Limited, and includes a barcode and coding area.*

FDA Label Image

Package Label-principal Display Panel (20 mg (1 x 14) Unit-dose Capsules)

Packaging label for Esomeprazole Magnesium Delayed-Release Capsules USP 20 mg by Aurobindo Pharma Limited. The label indicates the product contains 14 unit-dose capsules (1 x 14). It provides storage instructions and states the package is not child resistant. The product is distributed by Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (40 mg (30 Capsules Bottle))

Label for Esomeprazole Magnesium Delayed-Release Capsules USP 40 mg from Aurobindo Pharma Limited. Contains 30 capsules. Notes esomeprazole magnesium trihydrate USP equivalent to 40 mg esomeprazole per capsule. Distributed by Aurobindo Pharma USA, Inc. Storage instructions at 20° to 25°C. Includes barcode and coding area markings.*

FDA Label Image

Package Label-principal Display Panel (40 mg (10 x 10) Unit-dose Capsules)

Packaging label for Esomeprazole Magnesium Delayed-Release Capsules USP 40 mg by Aurobindo Pharma Limited. The box contains 100 unit-dose capsules (10 x 10). It includes storage instructions, dosage form, dosage strength, and distributor information for Aurobindo Pharma USA, Inc. The label emphasizes dispensing the medication guide to patients.*

FDA Label Image

Chemical Structure (Esomeprazole Str)

Chemical structure of esomeprazole magnesium hydrate. The image depicts the molecular arrangement including the magnesium ion complexed with two esomeprazole molecules and three water molecules (hydrate). Key chemical groups and bonds are shown in a detailed molecular diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.